Abstract

Alginate Oligosaccharides (AOs) are bioactive compounds prepared through the enzymatic degradation of alginate polysaccharides by alginate lyase. These Oligosaccharides have become a focus of growing interest in scientific community, largely because of their array of bioactive attributes, which include immunomodulatory, antioxidant, anti-inflammatory and prebiotic effects. This review critically examines the current scientific literature on Alginate Oligosaccharides (AOs), encompassing in vitro studies, animal models and preliminary human clinical trials. It also addresses the safety profiles of AOs, focusing on toxicological assessments, to provide a comprehensive view of their risk-to-benefit ratio. Additionally, the review assesses the existing information regarding the impact of Alginate Oligosaccharides (AOs) on human health. It aims to identify the current research gaps and outline potential future directions for their therapeutic application.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.